Evommune is set to make its stock market debut next week, but the biotech company is keeping investors guessing about its final share price.

Plus: Canva launches AI-powered design suite ahead of IPO; Russia denies nuclear testing, warns response if US breaks ...

It’s hard to find a leader in tech and finance who isn’t feverishly figuring out how to implement artificial intelligence in ...

According to a Reuters report published on Wednesday, OpenAI is laying the foundation for what could be one of the ...

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company ...

Navan is perhaps the most high-profile IPO over the past month, as the SEC's filing process has stalled with 90% of staff furloughed.

Operating revenue: Jumped 54% YoY to Rs 5,561 crore, and grew 12% sequentially from Rs 4,961 crore in the previous quarter.

The edtech giant Physicswallah is gearing up for a much-anticipated IPO that could raise Rs 3,820 crore, according to Bloomberg. Backed by WestBridge Capital LLP and Hornbill Capital Partners, ...

The proposed offering will include a fresh issue of shares worth ₹3,100 crore and a secondary sale of about ₹720 crore by ...

The $1 trillion report comes from “three people familiar with the matter.” Reuters’ sources claimed that OpenAI CFO Sarah ...

OpenAI hasn’t formally committed to an IPO, but CEO Sam Altman, in a livestream broadcast discussing the new structure, said ...

Procore (PCOR) is poised for strong growth with AI innovation, margin expansion, and a new CEO. Read here for more investment ...